Cat.#: ACPP-1305
| Despition | Aph 1b Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1327 | Dopamine Receptor D1 Blocking Peptide (AC1327) | 250 µg | inquiry |
| ACPP-1315 | GTP cyclohydrolase 1 Blocking Peptide (AC1315) | 250 µg | inquiry |
| ACPP-1237 | CRMP1 Blocking Peptide (AC1237) | 250 µg | inquiry |
| ACPP-1397 | Human RNLS Protein (AC1397) | 5 µg | inquiry |
| ACPP-1489 | Human PSPN Protein (AC1489) | 5 µg | inquiry |
| ACPP-1416 | Human VAMP1 Protein (AC1416) | 20 µg | inquiry |
| ACPP-1818 | Mouse FGF 9 Protein (AC1818) | 2 µg | inquiry |
| ACPP-1120 | Human NRG1 Protein (AC1120) | 10 µg | inquiry |
| ACPP-1514 | Human Thyroid Stimulating Hormone Receptor (Active) (A105346) (AC1514) | 2 µg | inquiry |
| ACPP-1132 | Recombinant Human Calbindin Protein (AC1132) | 25 µl | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.